View more job listings or post a job
Bioduro-Sundia Associate Director/Director in Laboratory Animal and Exploratory Toxicology
Variant Bio (Senior) Scientist - DMPK
Alturas Analytics Scientist 1
Eli Lilly and Company R-39973 Scientific Director ADME - Novel Modalities (Open)
FibroGen Director DMPK
Applied BioMath Technical Marketing Specialist
Post a job


[Free Online Workshop] Career Transition for Research Scientists: Career Overview, Project Management and Regulatory Affairs (jointly with BioPharmaPM and RAPS-SF)

Speakers: Toby Freedman, Synapsis Search Biotech Recruiting; Rachel Kindt, Rachel Kindt Consulting; Sandra Morris, MorTil Consulting; Mandana (Mondee) Baradar, UCB; Joseph Carlino, Carlino Consulting; Anne Wong, Gilead Sciences; Kamana Singh, APS Pharma Solutions; Clare Matti, Network Partners; Ann Lucchesi, LuCore Regulatory Affairs Services; April Nguyen, MMS
Organizers: Toby Freedman, Synapsis Search Biotech Recruiting; Rachel Kindt, Rachel Kindt Consulting; Sandra Morris, MorTil Consulting; Dean Wilson, PBSS
Date: 2024-05-30
Time: 8:30-11:30 Pacific Time
Registration fee: $0
Location: Online via Zoom
Major Sponsor:
Vendor show vendors registered to date:
Registration deadline:2024-05-29  (it will close sooner if the seating cap is reached)

About the Topic

Evolving career landscapes and interests can lead beyond the typical vertical climb through a given specialty in R&D. Fortunately, there are many paths potentially available for scientists seeking roles beyond the bench.
In this first PBSS workshop of a series, career transitions to Project Management (PM) and Regulatory Affairs will be explored, in collaboration with 2 Bay Area organizations: BioPharmaPM (BPPM), and the Regulatory Affairs Professionals Society - San Francisco (RAPS-SF). Experts from recruiting, career development, executive coaching, PM, and Regulatory will describe potential roles within PM and Regulatory, including lessons learned, personal advice and experiences, tips for success, desirable attributes, and pros and cons of the role. Introductions to the BPPM and RAPS-SF organizations will also provide useful resources and networking opportunities.

Subsequent workshops in the series will explore possibilities in Clinical Development, Clinical Operations, Commercial, Venture Capital, Business Development, Medical Affairs, Intellectual Property, and others
Time (PST) Topic Presenter(s)
8:30-8:50 am PBSS, BPPM, RAPS-SF Welcome and Introduction Shichang Miao (PBSS) Dean Wilson (PBSS) Mandana (Mondee) Baradar (BPPM) Kamana Singh (RAPS-SF) 
8:50-9:20 am Career Transition Opportunities: Finding and Following Your Path Toby Freedman, PhD, President, Synapsis Search Biotech Recruiting Rachel Kindt, PhD, Scientific Leadership Coach, Rachel Kindt Consulting
9:20-9:40 am Project Management: Overview (roles, attributes, paths, lessons learned) Sandra Morris, PhD, Board Member, Consultant, Executive Coach, MorTil Consulting
9:40-9:50 am PM Panelist presentation Mandana (Mondee) Baradar, MBA, Sr. Program Manager, UCB
9:50-10:00 am PM Panelist presentation Joseph Carlino, PhD, Principal, Carlino Consulting
10:00-10:10 am PM Panelist presentation Anne Wong, Associate Director, Global Program Management, Gilead Sciences
10:10-10:30 am Q&A (PM) PM presenters and panelists
10:30-10:40 am Break -
10:40-11:00 am Regulatory Affairs: Overview (roles, attributes, paths, lessons learned) Kamana Singh, MBA, Founder/Executive Consultant, APS Pharma Solutions
11:00-11:10 am Regulatory Panelist presentation Clare Matti, MS, Sr. Regulatory Affairs Consultant, Network Partners
11:10-11:20 am Regulatory Panelist presentation Ann Lucchesi, MS, Regulatory Affairs Professional, LuCore Regulatory Affairs Services
11:20-11:30 am Regulatory Panelist presentation April Nguyen, PharmD, RAC, MPH, Sr. Global Regulatory Affairs Manager, MMS
11:30-11:50 am Q&A (Regulatory) Regulatory presenters and panelists
11:50 am-12:30 pm Panel discussion All presenters and panelists

2024-06-20, Alzheimer's Disease: Untangling What We Thought We Knew and Future Precision Diagnostics and Therapeutics
2024-07-24, [Free Online] The Science and Stories of Promising Biotech Startups: Symposium No.6
2024-08-14, [Free Online] Advances in Cancer Therapeutics
2024-08-22, [Free Online] Diabetes and Obesity Treatments: Current and Emerging Landscapes of GLP-1, GIP, and Beyond
2024-09-10, [In-Person] Translational PK/PD and Human Dose Projections for Antibodies and Novel Therapeutic Modalities: Antibodies, ADCs, Covalent Inhibitors, Ocular and Neuro delivery, Vaccines, Bispecifics, Cell and Gene Therapies
2024-09-20, [In-Person] Nonclinical Safety Assessments of Biologics and Other Novel Modalities for IND/NDA/BLA Filings
2024-09-25, [Free Online] Development of Protein Degraders: Computational Modeling, Medicinal Chemistry and Early Development
2024-10-10, [In-Person] Regulatory Global Submission: Strategies and Best Practices for FDA, EMA and PMDA
2024-10-25, [Free Online Workshop] Unleashing the Power of Real-World Evidence / Data (RWE/RWD) to Facilitate Drug Discovery, Development, and Beyond
┬ęPharmaceutical & BioScience Society, International; Last Modified: 6/15/2024; Admin Logon
Ads (in random order)
Submit a Text Ad
($250 for 2 months)

Alturas Analytics, Inc. Expert Regulated & Non-Regulated LC-MS, GC-MS bioanalytical & PK/TK analysis of small & large molecules in any matrix. Discovery through phase IV.
Simulations Plus Join us for MIDD+ San Francisco, a free event June 6-7. Hear scientific presentations from industry leaders, train with experts & connect with peers.
Hypha Discovery Synthesis, purification & NMR characterization of phase I and II drug metabolites & API impurities at mg-g scale with COAs.
Lena Biosciences Predictive toxicology. Intrinsic & idiosyncratic drug-induced liver injury. Mitochondrial toxicity in a drug metabolism-competent model.
Submit a Text Ad